M C37 (Cetirizine 10 mg)
Pill imprint M C37 has been identified as Cetirizine hydrochloride 10 mg.
Cetirizine is used in the treatment of allergic rhinitis; urticaria and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Cetirizine 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M C37
- 10 mg
- 8.00 mm
- Rx and/or OTC
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0597||UDL Laboratories Inc|
|35356-0085||Lake Erie Medical and Surgical Supply (repackager)|
|67544-1294||Prepak Systems Inc (repackager)|
|55289-0995||PDRX Pharmaceuticals Inc (repackager)|
|16590-0538||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about cetirizine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.